Filed in archive
Developments
, Treatment
by Gloria Gamat on June 14, 2009
© RogueSun Media
From WebMD:
Byetta is the first of the class of type 2 diabetes drugs called GLP-1 analogs. The drug takes advantage of the body's own signaling system to increase insulin output in response to meals.
Byetta is a popular drug, and it's helped many patients. But liraglutide - soon to be called Victoza if approved by the FDA - works better, says Lawrence Blonde, MD, director of the diabetes clinical research unit at Ochsner Clinic Foundation, New Orleans.
"Our direct comparison study shows patients who took liraglutide once a day had a greater reduction in [average blood sugar levels] at the end of the 26-week study than did [Byetta] twice a day," Blonde tells WebMD. "Obviously, once-a-day injections would be preferred by many patients because of the convenience - and it is not tied to meals. Liraglutide can be taken any time as long as you take it the same time each day."
Remember that Byetta has been implicated in pancreatitis and death. And we thought it was the best thing that ever happened to diabetes treatment...
Byetta is a product of Amylin Pharmaceuticals and Eli Lily.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/153970
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Victoza: New Diabetes Drug, Better Than Byetta?:
|
Rating: 5.20 out of 5 vote(s) cast.
|
Response from:
Bill
(09/06/09 7:53pm)
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
http://www.fda.gov/ohrms/dockets/ac/09/transcripts/2009-4422t2.pdf